DOJ Expands AI and Data-Sharing Tools to Combat Healthcare Fraud in the US
The US Department of Justice has signed data-sharing deals with CMS, DHS, and the FTC to boost AI-driven healthcare fraud detection. Law firm morganlewis.com warns of broader implications for healthcare companies.
DOJ Deploys AI and Cross-Agency Data Agreements to Target Healthcare Fraud
The US Department of Justice (DOJ) has entered into a series of interagency data-sharing agreements with federal partners, significantly expanding its capacity to detect and prosecute healthcare fraud using artificial intelligence and advanced data analytics. As morganlewis.com reports, the announcement came on 23 June 2026, alongside the annual results of the Nationwide Health Care Fraud Takedown.
The Nationwide Health Care Fraud Takedown is a multiagency operation that has been running since 2007, when the Medicare Fraud Strike Force programme was established. Data analysis has been central to the initiative from the outset, but the latest round of agreements marks a notable expansion in both scope and sophistication.
DOJ Gains Direct Access to CMS Cloud Infrastructure
At the core of the new arrangements is an agreement between DOJ's recently created National Fraud Enforcement Division and the Centers for Medicare & Medicaid Services (CMS). Under the deal, the division will receive cloud computing capacity within CMS's Integrated Data Repository (IDR), allowing DOJ to apply AI and advanced analytics directly to Medicare and other government healthcare programme data.
CMS has also announced parallel moves to expand user verification processes and standardise data fields, making cross-dataset analysis more consistent and scalable.
Travel Records and Consumer Complaints Join the Mix
Beyond CMS data, DOJ struck agreements with two additional agencies. The arrangement with the Department of Homeland Security (DHS) will give investigators access to travel records, which may be used to flag off-premises billing by healthcare providers. The agreement with the Federal Trade Commission (FTC) will supply telemarketing and telemedicine consumer-complaint data.
Together, the agreements are designed to facilitate earlier detection of suspicious billing patterns, help identify emerging fraud trends, and accelerate investigations by connecting datasets that had previously remained separate.
Implications for Healthcare Companies
While the Takedown has historically centred on criminal prosecution of individual practitioners, morganlewis.com notes that the expanded use of data analytics carries broader consequences for healthcare organisations — including health systems, health plans, Medicare Advantage organisations, and pharmacy benefit managers.
Heightened visibility into billing patterns. With analytical tools embedded directly within CMS's IDR, DOJ may be able to identify statistical outliers, unusual utilisation patterns, aberrant coding, and reimbursement anomalies earlier in the claims lifecycle, reducing the lag between an anomaly and a formal investigation.
Earlier government intervention. The DOJ has stated that its goal is not only to identify fraud after payments are made, but to intervene before funds leave federal healthcare programmes altogether. This may translate into more frequent payment suspensions, accelerated audits, and earlier issuance of civil investigative demands and subpoenas.
Faster, more coordinated investigations. Cross-agency data access could allow investigators to link claims data with travel records from DHS and consumer complaints from the FTC, moving beyond the traditional focus on claims data and medical records. The result may be swifter cross-validation of red flags and quicker referrals to specialist enforcement teams.
False Claims Act exposure. Investigations previously driven largely by whistleblower allegations — so-called qui tam filings under the False Claims Act — may increasingly be initiated directly by DOJ based on AI-assisted claims analysis. Earlier in 2026, the head of DOJ's Commercial Litigation Branch remarked that "your next whistleblower could be your data."
Managed care and risk adjustment scrutiny. Recent enforcement priorities point to particular focus on Medicare Advantage, Medicaid managed care, risk adjustment practices, and payment integrity. If CMS succeeds in standardising data submissions across programmes, enforcement agencies may find it easier to compare utilisation, diagnoses, coding, and reimbursement practices — increasing scrutiny of, among other things, prior authorisation practices and coding documentation.
Record Enforcement Actions as Backdrop
The new data-sharing agreements sit within a broader federal push over the past year to increase coordination between enforcement agencies and leverage data analytics in fraud investigations, including under the civil False Claims Act. The announcements coincide with what the government has described as record-setting coordinated enforcement actions.
Morganlewis.com advises that healthcare companies — and organisations in other sectors that handle large volumes of data — should assess whether their compliance and internal auditing functions are keeping pace with the government's evolving analytical capabilities.
Source: Google News MT — Crime (en)